CMS To Develop Guidance On Coverage Decisions Requiring Registries
This article was originally published in The Gray Sheet
Executive Summary
CMS' emerging policy of attaching clinical trial or registry requirements as a condition of coverage will be clarified in an upcoming guidance
You may also be interested in...
Critical Path To Payment? Venture Capitalists Seek Medicare Refocus
The National Venture Capital Association is lobbying CMS to make better use of its Council on Technology & Innovations to streamline and standardize the reimbursement process for novel technologies
Critical Path To Payment? Venture Capitalists Seek Medicare Refocus
The National Venture Capital Association is lobbying CMS to make better use of its Council on Technology & Innovations to streamline and standardize the reimbursement process for novel technologies
FDA Guidance Development Offers Model For CMS – Device Stakeholders
CMS should assimilate FDA's policy of engaging industry early in the guidance development process, according to device stakeholders